Skip to content
Screener

Interest Expense at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
-$401M
Labcorp Holdings logo
Labcorp HoldingsLH
-$61.1M-207%
IQVIA logo
IQVIAIQV
$197M+8.2%
Fortrea Holdings Inc. logo
Fortrea Holdings Inc.FTRE
-$19.3M+17.2%
Lifecore Biomedical, Inc. logo
Lifecore Biomedical, Inc.LFCR
$3.93M+135%
NeoGenomics logo
NeoGenomicsNEO
$781K-16.3%

Segments

By segment

See full
Reportable Segment$4.99M+363%

Other financials

Income statement

See full
Revenue$707.3M+17.2%
Operating income$146.8M+16.2%
Net income$121.4M+34.5%
EPS (diluted)$4.25+37.1%

Balance sheet

See full
Cash & equivalents$502.7M+985%
Total debt$144.1M-3.8%
Total equity$433.9M+152%
Total assets$2.1B+30.9%

Cash flow

See full
Operating cash flow$162.0M+9.1%
CapEx$23.9M+291%
Free cash flow$138.1M-3.0%

Valuation

See full
Market cap$16.41B+35.7%
Enterprise value$16.05B+31.6%
P/E33.4×+4.5×
P/S5.9×+0.5×

Profitability

See full
Operating margin21%-0.4pp
Net margin17.7%-1.1pp
FCF margin25.4%-0.6pp

Returns & leverage

See full
Return on equity162.2%+72.8pp
Debt / equity0.3×-0.5×
Current ratio0.7×+0.3×

Where this comes from

Reported directly by Medpace Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InterestIncomeExpenseNonoperatingNet.

The source filing: Medpace Holdings, Inc.’s 10-Q, filed July 23, 2026.

Filed
Jul 23, 2026, 4:03 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001668397-26-000025
(Amounts in thousands, except per share amounts)Three Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Income from operations146,824126,335288,327239,858
Other income (expense), net:
Miscellaneous (expense) income, net(147)(2,875)824(4,691)
Interest income, net4,9861,07810,1037,541
Total other income (expense), net4,839(1,797)10,9272,850
Income before income taxes151,663124,538299,254242,708
Income tax provision30,30134,27854,02237,853
Net income$121,362$90,260$245,232$204,855

Item 1. Financial Statements (unaudited)

FAQ

What is Medpace Holdings, Inc.'s interest expense?
Medpace Holdings, Inc. (MEDP) reported interest expense of $4.99M in Q2 2026.
How has Medpace Holdings, Inc.'s interest expense changed year-over-year?
Medpace Holdings, Inc.'s interest expense increased by 362.5% year-over-year, from $1.08M to $4.99M.
What is the long-term trend for Medpace Holdings, Inc.'s interest expense?
Over 3 years (2021 to 2025), Medpace Holdings, Inc.'s interest expense has grown at a 395.6% compound annual growth rate (CAGR), from -$105K to $12.78M.
What does interest expense mean?
Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.

Ask your AI about Medpace Holdings, Inc.'s interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude